Blog

Unfolding the complex puzzle of science

The driving force behind science has always been curiosity. For me, I have always had an intrinsic curiosity to know more about why things happen the way they happen. From childhood, I loved to solve puzzles. To uncover the unknown and unfold the complex puzzle of science has always fascinated me. With strategy and method, science can unfold many of the unknown circumstances that occur in nature. The power of reasoning initially attracted me towards science and continues to do so till this day and I am proud to be a component towards a mass initiative to unearth the mysteries …

Simply put, science is amazing!

Growing up, perhaps I wasn’t as imaginative as my friends who wanted to be astronauts or famous singers. I just couldn’t comprehend the idea of choosing one career that I would be destined to for rest of my life. I do vaguely remember deciding to be a doctor at the age of about 6 or 7, but not for long as I soon realised that I am not one for blood and gore. I often look back and wonder how I came to a decision to forge a career in science. I was always an inquisitive child, spending hours in the outdoors, observing life …

Young Boy Businessman Launching a Rocket

The 2020 vision for the monoclonal antibody pipelines

Analysts have estimated that combined global sales of monoclonal antibody biopharmaceuticals will approach US$125 billion by 2020. Around 50 monoclonal antibody biologics have been approved in the United States and Europe for the treatment of range of serious diseases. A significant portion of the biopharmaceutical industry’s new product pipeline is comprised of monoclonal antibodies that are in the discovery or clinical manufacturing phases and the market for therapeutic monoclonal antibodies is becoming increasingly competitive. Ensuring commercial success In order to attract additional rounds of investment for future commercialization activities, biopharmaceutical companies must progress their candidates through process development and into …

Our Science and Innovation Strategy: Leading Through Innovation

At the end of this month, myself and FUJIFILM Diosynth Biotechnologies CEO, Steve Bagshaw, will be attending and presenting at the Industrial Biotechnology Innovation Center (IBioIC) Annual Conference 2019, ‘Industrial Biotechnology for a Sustainable Future’, which takes place on Wednesday 30th and Thursday 31st January 2019 in the Technology Innovation Center, Glasgow. IBioIC’s Annual Conference is the leading general IB conference in the UK. The conference celebrates the success of the biotechnology industry in the UK and provides delegates with the networking opportunities needed to drive new collaborations. IBioIC is a specialist in the Industrial Biotechnology (IB) sector, aimed at …

365 Opportunities to make a difference

Every New Year brings with it hope and possibilities. As we enter 2019, we are ready to embrace the new opportunities that will come with it. There are many quotes and ideas on what a new year represents. There is one in particular that stands out as this is being written: “A new year brings with it 365 opportunities.”  This quote stood out because it goes beyond words as it exerts the notion of action. Opportunities are there for those who take them. Opportunities are there, every day, to make a difference to and for ourselves; to and for our communities; …

Subscribe to blog updates